Your browser is no longer supported. Please, upgrade your browser.
Settings
AXLA Axcella Health Inc. daily Stock Chart
AXLA [NASD]
Axcella Health Inc.
Index- P/E- EPS (ttm)-2.55 Insider Own0.30% Shs Outstand29.20M Perf Week-0.43%
Market Cap147.97M Forward P/E- EPS next Y-2.30 Insider Trans- Shs Float27.15M Perf Month-10.25%
Income-62.00M PEG- EPS next Q-0.44 Inst Own68.60% Short Float1.23% Perf Quarter-11.11%
Sales- P/S- EPS this Y55.40% Inst Trans88.29% Short Ratio1.27 Perf Half Y36.47%
Book/sh3.18 P/B1.46 EPS next Y-75.70% ROA-61.10% Target Price- Perf Year-12.62%
Cash/sh3.80 P/C1.22 EPS next 5Y0.00% ROE-90.30% 52W Range2.25 - 7.73 Perf YTD15.71%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-39.97% Beta-
Dividend %- Quick Ratio11.30 Sales past 5Y- Gross Margin- 52W Low106.22% ATR0.35
Employees69 Current Ratio11.30 Sales Q/Q- Oper. Margin- RSI (14)48.78 Volatility9.68% 6.95%
OptionableNo Debt/Eq0.27 EPS Q/Q49.80% Profit Margin- Rel Volume0.53 Prev Close4.71
ShortableYes LT Debt/Eq0.21 EarningsAug 05 BMO Payout- Avg Volume263.17K Price4.64
Recom1.40 SMA20-0.74% SMA50-6.20% SMA2001.52% Volume141,977 Change-1.49%
Sep-25-20Initiated B. Riley FBR Buy $14
Jul-31-20Initiated Piper Sandler Overweight $25
May-28-20Initiated Wedbush Outperform $28
May-01-20Initiated BTIG Research Buy $10
Jun-03-19Initiated SVB Leerink Outperform $21
Jun-03-19Initiated JP Morgan Overweight $20
Jun-03-19Initiated Goldman Buy $25
Sep-24-20 03:35PM  
Sep-08-20 08:00AM  
Aug-27-20 08:00AM  
Aug-20-20 07:30AM  
Aug-17-20 07:30AM  
Aug-13-20 08:49AM  
Aug-11-20 10:19AM  
Aug-07-20 09:53AM  
Aug-05-20 10:41AM  
Aug-03-20 08:00AM  
Jul-27-20 10:25AM  
Jul-15-20 11:30AM  
Jul-09-20 09:42AM  
Jul-07-20 08:00AM  
Jul-01-20 08:03AM  
Jun-24-20 12:00PM  
11:30AM  
Jun-22-20 11:02PM  
Jun-17-20 09:50AM  
08:00AM  
Jun-15-20 10:59AM  
Jun-12-20 10:23AM  
Jun-11-20 10:44PM  
10:21AM  
Jun-03-20 08:00AM  
Jun-02-20 11:30AM  
Jun-01-20 12:09PM  
May-28-20 08:00AM  
May-22-20 06:21AM  
May-18-20 04:05PM  
May-15-20 11:30AM  
May-13-20 10:31PM  
May-11-20 08:00AM  
May-06-20 08:00AM  
May-05-20 04:05PM  
May-04-20 04:05PM  
Apr-29-20 11:30AM  
Apr-20-20 08:53AM  
Apr-07-20 08:00AM  
Mar-30-20 12:00PM  
08:06AM  
Mar-23-20 04:01PM  
Mar-05-20 08:00AM  
Feb-26-20 07:30AM  
Feb-19-20 08:00AM  
Jan-09-20 08:00AM  
Jan-08-20 08:00AM  
Jan-07-20 02:31PM  
Dec-21-19 03:44PM  
Dec-19-19 08:00AM  
Dec-07-19 08:00AM  
Dec-05-19 05:11AM  
Nov-25-19 08:00AM  
Nov-20-19 08:00AM  
Nov-12-19 04:05PM  
Nov-08-19 08:00AM  
Nov-06-19 08:00AM  
07:08AM  
Oct-23-19 07:30AM  
Oct-11-19 05:49PM  
Oct-07-19 08:30AM  
Oct-01-19 04:11PM  
Sep-03-19 05:45AM  
Aug-23-19 04:27PM  
Aug-12-19 05:06PM  
Aug-08-19 10:48AM  
Aug-07-19 05:54PM  
Jul-31-19 08:00AM  
Jun-20-19 05:10PM  
May-13-19 05:30PM  
May-08-19 08:40PM  
07:11AM  
May-06-19 06:08PM  
May-04-19 05:25PM  
Axcella Health Inc., a clinical-stage biotechnology company, researches and develops endogenous metabolic modulators (EMMs) for the treatment of complex diseases and improving health in the United States. It offers AXA1665 for use in treating overt hepatic encephalopathy; AXA1125 and AXA1957 to treat non-alcoholic steatohepatitis; AXA2678 for use in treating muscle atrophy; and AXA4010 to target multiple biological pathways to support normal structures and functions of the blood. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was founded in 2008 and is based in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Nestle Health Science US Holdi10% OwnerMay 18Buy4.751,936,8429,200,0004,305,541May 21 05:02 PM
Epstein David RDirectorMay 18Buy4.7550,000237,500118,103May 20 04:07 PM
Flagship Ventures Fund IV Gene10% OwnerMay 18Buy4.753,800,00018,050,0004,808,780May 20 05:15 PM
Epstein David RDirectorFeb 28Buy3.752,0057,51968,103Mar 02 07:04 PM
Epstein David RDirectorFeb 27Buy3.6512,80046,72066,098Mar 02 07:04 PM
Chardonnet LaurentChief Financial OfficerJan 31Buy4.943,00014,8203,665Jan 31 08:44 PM
Chardonnet LaurentChief Financial OfficerJan 27Buy4.943521,739665Jan 28 06:39 PM
Chardonnet LaurentChief Financial OfficerJan 24Buy4.923131,540313Jan 28 06:39 PM
Sohn Catherine A.DirectorJan 17Buy4.871,0004,8701,000Jan 21 04:38 PM
Epstein David RDirectorNov 27Buy3.911,0053,93053,298Dec 02 07:31 PM
Epstein David RDirectorNov 27Buy3.911,0053,93053,298Dec 03 11:20 AM
Epstein David RDirectorNov 26Buy3.5514,00049,70052,293Dec 03 11:20 AM
Epstein David RDirectorNov 26Buy3.5514,00049,70052,293Dec 02 07:31 PM